|
Real-time Estimate
Cboe BZX
10:44:21 2026-11-03 EST
|
5-day change | 1st Jan Change | ||
| 9.155 USD | +15.45% |
|
-48.68% | -46.70% |
| 10-30 | Bicara Therapeutics Shares Fall After Goldman Sachs Downgrade | MT |
| 10-30 | Goldman Sachs Downgrades Bicara Therapeutics to Sell From Neutral, $8 Price Target | MT |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| BCAX | Delayed | |
CBOE
| BCAX | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 13.8 | 16.42 | 17.07 |
| Spread/Res. | -35.00% | -45.37% | -47.45% |
| Spread/Supp. | +76.05% | +76.05% | +59.58% |
| Support | 5.095 | 5.095 | 5.621 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- BCAX Stock
- Charts Bicara Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
